@article{36cb1e2674fc4099ae18622826642410,
title = "The importance of early and proactive use of long-Acting injectable antipsychotics in the management of schizophrenia",
author = "Hiroyoshi Takeuchi",
note = "Funding Information: H.T. has received grants from Daiichi Sankyo and Novartis Pharma; speaker{\textquoteright}s fees from EA Pharma, Eisai, Kyowa, Janssen, Lundbeck, Meiji Seika Pharma, MSD, Otsuka, Sumitomo Pharma, Takeda, and Yoshitomiyakuhin; and consulting fees from Janssen, Mitsubishi Tanabe Pharma, Ono, and Sumitomo Pharma.",
year = "2023",
month = may,
day = "1",
doi = "10.1097/YIC.0000000000000463",
language = "English",
volume = "38",
pages = "182--183",
journal = "International Clinical Psychopharmacology",
issn = "0268-1315",
publisher = "Lippincott Williams and Wilkins",
number = "3",
}
